Privia Health Group, Inc. 是一家位于美国的人口健康技术和医疗实践管理公司。
财务指标
营业收入
2026-06-30
$6.32亿
2026-03-31
$6.03亿
2025-12-31
$5.41亿
2025-09-30
$5.8亿
营业支出
2026-06-30
$6.2亿
2026-03-31
$4960.7万
2025-12-31
$3837.7万
2025-09-30
$4660.1万
净利润
2026-06-30
$904.8万
2026-03-31
$306.4万
2025-12-31
$915.1万
2025-09-30
$686.1万
净利润率
2026-06-30
1.43%
2026-03-31
0.5%
2025-12-31
1.69%
2025-09-30
1.18%
每股收益
2026-06-30
$0.07
2026-03-31
$0.19
2025-12-31
$0.07
2025-09-30
$0.29
息税折旧摊销前利润
2026-06-30
$2010.7万
2026-03-31
$1259.1万
2025-12-31
$1602.8万
2025-09-30
$1944万
有效税率
2026-06-30
41.89%
2026-03-31
60.15%
2025-12-31
20.83%
2025-09-30
41.18%
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$6.32亿
$6.03亿
$5.41亿
$5.8亿
营业支出
$6.2亿
$4960.7万
$3837.7万
$4660.1万
净利润
$904.8万
$306.4万
$915.1万
$686.1万
净利润率
1.43%
0.5%
1.69%
1.18%
每股收益
$0.07
$0.19
$0.07
$0.29
息税折旧摊销前利润
$2010.7万
$1259.1万
$1602.8万
$1944万
有效税率
41.89%
60.15%
20.83%
41.18%
常见问题
PRVA represents the common stock of Privia Health Group, Inc., a healthcare technology company. The shares trade on the Nasdaq Global Select Market, allowing investors to participate in the company's performance. PRVA stock provides exposure to a business focused on physician enablement and value-based care. The stock's price, trading volume, and other real-time data are available on the PRVA quote page.
PRVA operates within the healthcare sector, specifically in healthcare technology and physician practice management. Its business model centers on providing a platform that supports independent physicians and practices with technology, administrative services, and population health management. The company also facilitates participation in value-based care arrangements, positioning it at the intersection of healthcare services and health information technology.
The latest PRVA stock performance, including daily price changes and recent trends, is displayed on the stock detail page. Since price movements are subject to market conditions, the most accurate and current performance data should be referenced directly from the live quote and charts provided. This ensures you see up-to-date information without relying on stale or hypothetical figures.
Valuation of PRVA can be assessed through metrics such as price-to-sales, price-to-earnings, and enterprise value-to-EBITDA, compared with peers in the healthcare technology and physician enablement space. Because these metrics fluctuate with stock price and financial results, the exact values are not fixed. Investors should review the latest financial statements and any valuation ratios shown on the PRVA page for current context.
PRVA shares may be eligible for pre-market and after-hours trading sessions, depending on your brokerage. These extended sessions typically have lower liquidity and wider spreads than regular market hours. Not all brokers offer this feature, and trading outside standard hours carries additional risks. Check with your broker and view the PRVA quote page for available session information.
Risks specific to PRVA include dependence on relationships with physician practices, regulatory changes in healthcare reimbursement, and competition from other healthcare technology platforms. Broader market risks, such as economic downturns and interest rate shifts, can also affect the stock. Additionally, as a growth-oriented company, PRVA may be sensitive to changes in investor sentiment and quarterly performance relative to expectations.